IP Library Granted Patent US 9,206,458
Granted Patent B2
US 9,206,458 · App. 14/070,498 · Granted Dec 8, 2015

Effects of alteration of expression of the MtfA gene and its homologs on the production of fungal secondary metabolites

Inventors: Ana M. Calvo-Byrd (Dekalb, IL); Vellaisamy Ramamoorthy (Dekalb, IL)
Assignee: Board of Trustees of Northern Illinois University
C12P37/00C07K14/37C12N1/14C12P1/02C12P7/66C12P17/181
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,206,458
App. No.
14/070,498
Granted
Dec 8, 2015
Kind
B2
Abstract

Many fungal secondary metabolites are of industrial interest, such as antibiotics, while others are undesirable compounds such as mycotoxins. Overexpression of mtfA enhances production of fungal compounds with applications in the medical field, and overexpression or impaired mtfA expression decreases the production of compounds that negatively affect health/agriculture/economy such as mycotoxins.

Claims (23)

1. A genetically modified fungal strain selected from the strains listed in FIG. 11 wherein the modification is in an mtfA homolog.

2. A method to control expression of secondary metabolites by fungal genes encoding a fungal transcription factor , the method comprising:

(a) selecting a gene encoding a fungal transcription factor; and

(b) manipulating expression of the gene in a fungal strain of claim 1 to increase or decrease expression products.

3. The method of claim 2 wherein manipulating is deleting the gene or a part of the gene.

4. The method of claim 2 wherein manipulating is interrupting the coding region of the gene with an insertion.

5. The method of claim 2 wherein the secondary metabolites are selected from the group consisting of mycotoxins and antibiotics.

6. A method to improve production of desirable secondary metabolites during fermentation or reduce undesirable products, the method comprising:

(a) increasing the production of secondary metabolites by increasing expression of mtfA encoding a fungal transcription factor;

(b) decreasing the production of undesirable products of fermentation by not expressing a gene encoding a fungal regulator; and

(c) coordinating expression of the genes in the fungal strain of claim 1 to achieve a predetermined combination of products.

7. The method of claim 6 wherein a desirable secondary metabolite is penicillin.

8. The method of claim 6 wherein an undesirable product is selected from the group consisting of mycotoxin and aflatoxin.

9. The method of claim 2 where the fungal transcription factor is MtfA.

10. A method to increase production of penicillin from a fungus, the method comprising:

(a) obtaining the fungal strain of claim 1 capable of producing penicillin; and

(b) causing the fungal strain to overexpress the mtfA gene encoding the MtfA protein.

11. A method to reduce sexual and asexual development of a fungus, the method comprising:

(a) obtaining the fungus; and

(b) manipulating expression of the gene encoding MtfA with an insertion or deletion in the gene.

12. A modification of the mtfA genetic locus in a fungal strain of claim 1 , wherein the modification is selected from the group consisting of a deletion, alteration and overexpression.

13. A DNA cassette producing the modification of claim 1 .

14. The fungal strain of claim 1 selected from the group consisting of TRVΔ mtfA and TRVΔ60.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 6, 2021
From: BOARD OF TRUSTEES OF NORTHERN ILLINOIS UNIVERSITY
To: NORTHERN ILLINOIS RESEARCH FOUNDATION
Reel/Frame 057712/0237 →
CONFIRMATORY LICENSE Recorded Aug 5, 2016
From: NORTHERN ILLINOIS UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 039595/0352 →
CONFIRMATORY LICENSE Recorded Sep 11, 2014
From: NORTHERN ILLINOIS UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 033726/0241 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 28, 2014
From: CALVO-BYRD, ANA M.; RAMAMOORTHY, VELLAISAMY
To: BOARD OF TRUSTEES OF NORTHERN ILLINOIS UNIVERSITY
Reel/Frame 032132/0339 →
Continuity (3)
Continuation In Part 14070094 · Nov 1, 2013
Provisional Application 61721777 · Nov 2, 2012
Related Publication 20140134671A1 · May 15, 2014